Castle Biosciences to Acquire Myriad MyPath Laboratory
Castle Biosciences’ acquisition of CLIA-certified Myriad MyPath Laboratory from Myriad Genetics will expand its suite of genomic tests for skin cancer.
Read More
Search Results for: genetic testing
The Long-Haul Role of Laboratory Diagnostics Post-COVID
While the tide is turning on COVID-19, clinical labs will continue to test long-haulers and the effects of the virus for years to come.
Read MoreThe Importance of Extended Antigen Typing in Transfusion Medicine
Tony Casina discusses the role of extended antigen typing or phenotyping in Transfusion Medicine. How this practice plays a significant role in transfusion of sickle cell, thalassemia and myelodysplastic syndrome patients as well as other chronically transfused patients.
Read More
The New FISH: Welcome to Cytogenetics 2.0
Advances in technology is making fluorescence in situ hybridization (FISH) more efficient, cost effective, and robust.
Read More
PerkinElmer to Acquire IVD Company Immunodiagnostic Systems Holdings
The acquisition will enable PerkinElmer to combine its channel expertise and testing capabilities with IDS’s chemiluminescence products in endocrinology, autoimmunity, and infectious diseases.
Read More